B-RAF with PLX4032

From Proteopedia

Revision as of 09:49, 3 January 2019 by Michal Harel (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search

B-RAF with PLX4032

PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.


BRAF kinase domain complex with PLX4032 (PDB code 3og7)

Drag the structure with the mouse to rotate









Proteopedia Page Contributors and Editors (what is this?)

J.D. Woodruff, Jens Hemmingsen, Michal Harel

Retrieved from "http://52.214.119.220/wiki/index.php/B-RAF_with_PLX4032"
Personal tools